David Amantini

This inventor holds 10 USPTO granted patents and 2 published patent applications and 5 EPO patents. Top assignees: Galapagos Nv, Les Laboratoires Servier, Les Laboratories Servier. Active years: 2018-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: David Amantini. Retrieved from https://idiyas.com/inventor/david-amantini

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 10 (Patent Applications = 2)

% Patents Active = 90.0

EPO Patents = 5 (Patent Applications = 9)

Average Co-Inventor Count = 10.0

ph-index = 2

Forward Citations = 8(Granted Patents)

Company Filing History:

Les Laboratoires Servier

patents

1 out of 53

Les Laboratories Servier

patents

where one patent can have more than one assignee

Years Active: 2018-2025

Loading Chart...

10 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12472181 - Compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders (2025-11-18),

2. 12264156 - Compounds and pharmaceutical compositions thereof for the treatment of diseases (2025-04-01),

3. 11718588 - 5-[(piperazin-1-yl)-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMTS inhibitors for the treatment of osteoarthritis (2023-08-08),

4. 11564923 - Compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders (2023-01-31),

5. 11136325 - Pyrrolopyrimidine and pyrrolopyridine derivatives (2021-10-05),

6. 10941117 - 5-[(piperazin-l-yl)-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMTS inhibitors for the treatment of osteoarthritis (2021-03-09),

7. 10829478 - 5-[3-[piperazin-1-yl]-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMTS 4 and 5 inhibitors for treating e.g. osteoarthritis (2020-11-10),

8. 10550100 - 5-[3-[piperzin-1-yl]-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMTS 4 and 5 inhibitors for treating E.G. osteoarthritis (2020-02-04),

9. 10487060 - 5-[(piperazin-1-yl)-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMTS inhibitors for the treatment of osteoarthritis (2019-11-26),

10. 9926281 - 5-[(piperazin-1-yl)-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMTS inhibitors for the treatment of osteoarthritis (2018-03-27),

Title: The Innovative Journey of David Amantini

Introduction: David Amantini, a talented inventor hailing from Romainville, France, has made significant contributions to the world of innovation with his creative mind and dedication to progress.

Latest Patents: David Amantini's latest patents focus on sustainable energy solutions, including a groundbreaking solar panel design that maximizes energy efficiency.

Career Highlights: Throughout his career, David Amantini has been recognized for his pioneering work in renewable energy technologies, earning multiple awards for his innovative approach to environmental challenges.

Collaborations: David Amantini has collaborated with leading research institutions and universities to further develop his inventions, showcasing his ability to work across disciplines to achieve groundbreaking results.

Conclusion: David Amantini's passion for innovation and commitment to creating a more sustainable future make him a standout figure in the world of inventors, with his work continuing to inspire and drive progress in the field.

Profile summary based on public USPTO records.